RapidPulse closes oversubscribed $48 million Series B round co-led by Medtronic, S3 Ventures
MDT•MDT•MDT•MDT•The round was co-led by Medtronic, TechWald Next and S3 Ventures. The syndicate also included SBI Investment, Florida Opportunity Fund and Santé Ventures.
Funding will also back expansion of RapidPulse’s pulsed aspiration platform, including a broader catheter size lineup.
RapidPulse said it closed an oversubscribed $48 million Series B round to fund clinical development of its stroke aspiration thrombectomy system.
The company said proceeds will be used to complete the TURBO IDE study in the US and Europe and support a planned FDA approval filing, subject to results.
